Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
XBXenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO)

NASDAQ Capital Market · Currency in USD
$1.72 ▼ -0.21 (-10.88%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.71 ▼ -0.01 (-0.58%)
Pre-market: Oct 26, 4:16 AM ET

Summary

Previous Close
$1.93
Open
$1.82
Day's Range
$1.72 – $1.82
52 Week Range
$1.72 – $4.94
Volume
22,636
Avg. Volume
67,331
Market Cap
$4.03M
Beta (5Y Monthly)
2.20
PE Ratio (TTM)
--
EPS (TTM)
-$1.08
Earnings Date
Nov 6, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Xenetic Biosciences, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
2
CEO
James F. Parslow

Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART. This cutting-edge personalized chimeric antigen receptor T cell (CAR T) platform is specifically engineered to identify and attack distinct tumor neoantigens found in individual patients. Beyond this specialized area, the company actively engages in the discovery, investigation, and creation of advanced biologic medicines and cancer treatments.

Earnings

Next report: Fri, Nov 6, 2026
DateEst.Actual
Aug 6, 2026–-$0.41
May 12, 2026–-$0.20
Mar 12, 2026-$0.52-$0.22Beat
Nov 12, 2025-$0.49-$0.33Beat
Aug 12, 2025-$0.64-$0.45Beat
May 12, 2025-$0.72-$0.59Beat

Analyst view

Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on XBIO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.